DOTAGA. (SA.FAPi) 2 (TFA)
DOTAGA. (SA.FAPi) 2 TFA is a potent dimeric fibroblast-activation protein inhibitor (FAPi) . DOTAGA. (SA.FAPi) 2 TFA has the potential for cancer diagnosis research[1].
Product Specifications
UNSPSC
12352005
Target
FAP
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dotaga-sa-fapi-2-tfa.html
Purity
97.51
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(O)CN1CCN(C(CCC(NCCNC(C2=O)=C(NCCCCOC3=CC4=C(N=CC=C4C(NCC(N5[C@H](C#N)CC(C5)(F)F)=O)=O)C=C3)C2=O)=O)C(O)=O)CCN(CCN(CC1)CCNC(C6=O)=C(NCCCCOC7=CC8=C(N=CC=C8C(NCC(N9[C@H](C#N)CC(C9)(F)F)=O)=O)C=C7)C6=O)CC(O)=O.OC(C(F)(F)F)=O
Molecular Formula
C73H84F7N17O19
Molecular Weight
1636.54
References & Citations
[1]Tilman Läppchen, et al. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA. (SA.FAPi) 2. Molecules. 2024 Jun 28;29 (13) :3093.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
